Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NPY4R | P50391 | 18/20 | 0.49 |
| ▸ | NPY1R | P25929 | 11/20 | 0.49 |
| ▸ | NPY5R | Q15761 | 10/20 | 0.49 |
| ▸ | NPY2R | P49146 | 7/20 | 0.49 |
| ▸ | CACNA1B | Q00975 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27115303 | 0.88 | NPY4R (0.55) | NPY4RNPY1RNPY5RNPY2RCACNA1B | |
| SCHEMBL30958040 | 0.86 | NPY4R (0.49) | NPY4RNPY1RNPY5RNPY2RCACNA1B | |
| SCHEMBL10168593 | 0.86 | NPY4R (0.55) | NPY4RNPY1RNPY5RNPY2R | |
| SCHEMBL18758146 | 0.83 | NPY4R (0.51) | NPY4RNPY1RNPY5RNPY2R | |
| SCHEMBL15963839 | 0.82 | NPY4R (0.48) | NPY4RNPY1RNPY5RNPY2R | |
| SCHEMBL10169049 | 0.81 | NPY4R (0.52) | NPY4RNPY1RNPY5RNPY2R | |
| SCHEMBL15826828 | 0.81 | NPY4R (0.47) | NPY4RNPY1RNPY5RNPY2R | |
| SCHEMBL24221401 | 0.80 | NPY4R (0.37) | NPY4RNPY1RNPY5RNPY2R | |
| SCHEMBL1276063 | 0.80 | NPY4R (0.37) | NPY4RNPY1RNPY5RNPY2R | |
| SCHEMBL10169230 | 0.80 | NPY4R (0.54) | NPY4RNPY1RNPY5RNPY2R |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20120040893-A1 | MODIFICATION OF FEEDING BEHAVIOUR | COWLEY MICHAEL (AU) | 2012-02-16 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120040893-A1 | MODIFICATION OF FEEDING BEHAVIOUR | GLP1R, NPY4R, NPY1R | NPY4R 2/4885NPY1R 3/4885NPY5R 6/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.